2nd WORLD CONFERENCE ON BREAST CANCER AND THERAPEUTICS
HYBRID EVENT | Nov 21- 22, 2024 | BANGKOK, THAILAND
Theme: Congregation of the Recent Revolution and Medicaments of Breast Cancer
Anna Tompa
Semmelweis University, HungaryTitle: Hungarian Nurs Study: Long term monitoring and follow-up among hospital nurses, handling cytostatic drugs
Abstract
Background:
We have carried out a multiple end-point approach genotoxicology monitoring of nurses exposed to cytostatics since 1992, in order to follow-up the improvement in work-related conditions. In 2000 the Public Act No. XXV on Chemical Safety (11th April 2000, conforming to the directives of European Union 67/548/EEC) and the 26/2000 order of the Ministry of Health (30.Sept.2000) on the Protection against occupational carcinogenic substances and prevention of health damages caused by carcinogenic substances were elaborated. In 2004 the methodological guidelines of the National Institute of Pharmacy, Hungary on manufacturing and use of mixed cytostatic infusions was issued.
Methods:
The guidelines in these regulations on the protection against exposure to carcinogenic agents and for the performance of environmental and biological monitoring at workplaces with higher cancer risk were largely based on the results of the follow-up genotoxicological and immunotoxicological monitoring of nurses exposed to cytostatics made by the our cytogenetic laboratory at the National Institute of Chemical Safety. Chromosomal studies are based on peripheral blood lymphocyte (PBL) cultures, which may present mutations as a cytogenetic change on chromosome structures.
Results:
Our genotoxicological and immunotoxikological biomarkers are suitable to indicate the need for intervention in high cancer risk groups. In those cases, where removal of environmental hazards are not efficient enough in preventive measures since they’ve already suffered irreversible genetic damages, it may be possible to introduce chemoprevention, which includes changes in lifestyle, smoking and drinking habits as well as prescription of vitamins, antioxidants, minerals etc.
Biography
Professor Anna Tompa was graduated in medicine in Budapest Semmelweis Medical University and became an assistant professor at the Institute of Pathology and Cancer Research of the School of Medicine. After specialized in pathology she went to the United States to study the advanced methodology of experimental cancer research.. She has continued her research activities focused on the cancer prevention and obtained her D.Sc. in 1999 from Hungarian Academy of Sciences. She has written more, than 160 publications and given about 200 scientific lectures in different domestic and international congresses. She is a member of numerous domestic and international scientific societies, and presently she is emeritus fellow of Ramazzini Collegium and OECD expert in chemical safety. Today she is an emeritus professor and vice director of Public Health Institute in the Semmelweis University, Budapest, Hungary.
Organization Location
1309 Coffeen Avenue, STE 1200, Sheridan, Wyoming 82801, USA
Mail us at
Drop us an email for Program enquiry
cancerscience@scientexconferences.com
General Queries
cancersciences@scientexevents.com
Contact us
breastcancertherapy@scientexevents.org
cancersciences@scientexevents.com
Our Social Presence
Call us at
USA :+1 307 216 5923